R&D spending of local drugmakers and medical device manufacturers on the rise

Published: 2013-10-08 06:59:00

Updated: 2013-10-08 06:59:00

Korean companies producing medicines and medical devices have been spending more on research and development (R&D) projects to strengthen their technology leadership.

The Korea Health Industry Development Institute said Monday that the combined R&D spending by 61 pharmaceutical companies came ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK